News
Hemophilia B drug available in larger vial
CSL Behring has announced that Idelvion (Coagulation Factor IX [Recombinant], Albumin Fusion Protein) is now available in a 3500 IU vial size....
News
Team identifies potential immunotherapy target for AML
New research could aid the development of immunotherapies tailored to patients with acute myeloid leukemia (AML) who are undergoing stem cell...
News
Mechanism of cGVHD response to ECP still unclear
A prospective study did not reveal the mechanism driving response to extracorporeal photopheresis (ECP) in patients with chronic graft-versus-host...
News
First CAR T-cell therapy approved in Canada
Health Canada has authorized use of tisagenlecleucel (Kymriah™), making it the first chimeric antigen receptor (CAR) T-cell therapy to receive...
News
CAR T-cell therapy will soon be available in England, NHS says
The National Health Service (NHS) of England has announced that tisagenlecleucel (Kymriah®), a chimeric antigen receptor (CAR) T-cell therapy,...
News
Humans may have more HSCs than we thought
Humans may have ten times more hematopoietic stem cells (HSCs) than previously thought, according to research published in Nature. Researchers...
News
TYK2 inhibitors could treat ALCL, team says
Preclinical research indicates that TYK2 inhibitors could be effective in treating anaplastic large-cell lymphoma (ALCL). Researchers found...
News
Research may help explain how VOCs occur
Researchers say they have gained new insight that may help explain how vaso-occlusive crises (VOCs) occur in patients with sickle cell disease (...
News
Study authors fail to disclose industry payments
New research suggests investigators involved in oncology trials sometimes fail to disclose payments from the pharmaceutical industry. Researchers...
News
Caplacizumab approved to treat aTTP
The European Commission has granted marketing authorization for caplacizumab (Cablivi™), a humanized bivalent nanobody that inhibits the...
News
Daratumumab approved for new indication in MM
The European Commission (EC) has approved a new indication for daratumumab (Darzalex®). The drug is now authorized for use in combination with...
News
Factor VIII product approved for hemophilia A
The US Food and Drug Administration (FDA) has approved Jivi® (antihemophilic factor [recombinant] PEGylated-aucl) for the treatment of hemophilia...
News
PLK1 inhibitor receives orphan designation for AML
The European Commission has granted orphan drug designation to onvansertib for the treatment of acute myeloid leukemia (AML). Onvansertib (...
News
A new standard of care in hemophilia A?
Results of a phase 3 trial showed that prophylaxis with emicizumab significantly reduced bleeds, compared to no prophylaxis, in patients with...
News
EC approves blinatumomab for kids
The European Commission (EC) has expanded the approved indication for blinatumomab (Blincyto®), a bispecific, CD19-directed, CD3 T-cell engager...